Yamamoto T, Nagano H, Sakon M, Miyamoto A, Kondo M, Arai I, Morimoto O, Dono K, Umeshita K, Nakamori S, Murakami T, Nakamura H, Monden M
Dept. of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University.
Gan To Kagaku Ryoho. 2001 Oct;28(11):1718-23.
We report a patient with hepatocellular carcinoma (HCC) with portal vein thrombosis in the 1st branch who was treated by transcatheter arterial embolization (TAE) and survived more than 3 years. A 58-year old male was diagnosed as having unresectable massive type HCC in the area of S8 with portal vein thrombosis from the P8 branch to the right portal branch. He was treated by TAE via the anterior branch of right hepatic artery. One week later, localized hepatic infarction in the anterior segment was recognized. Five months later, the portal vein thrombosis had disappeared and become necrotic. After 3 years and 4 months, he died of a relapse of a gastric varix, but with no portal thrombosis and a well controlled intra-hepatic recurrence that was treated by repeated TAE. This case suggests that TAE might be effective for cases of HCC with portal vein thrombosis in the 1st branch, if the liver function and portal flow are suitable.
我们报告了一例肝细胞癌(HCC)患者,其肝门静脉第一分支发生血栓形成,经导管动脉栓塞术(TAE)治疗后存活超过3年。一名58岁男性被诊断为S8区不可切除的巨块型HCC,伴有从P8分支至右门静脉分支的门静脉血栓形成。通过右肝动脉前支对其进行TAE治疗。一周后,发现前段局部肝梗死。五个月后,门静脉血栓消失并坏死。3年4个月后,患者死于胃静脉曲张复发,但无门静脉血栓形成,肝内复发得到良好控制,通过重复TAE进行治疗。该病例表明,如果肝功能和门静脉血流合适,TAE可能对肝门静脉第一分支血栓形成的HCC病例有效。